Regional variations in the prevalence of multiple sclerosis in French farmers Regional variations in the prevalence of multiple sclerosis in French farmers2018-01-17T17:05:35-05:00
Regional variations in the prevalence of multiple sclerosis in French farmers Regional variations in the prevalence of multiple sclerosis in French farmers2018-01-17T17:05:35-05:00
Natural history of multiple sclerosis: risk factors and prognostic indicators Natural history of multiple sclerosis: risk factors and prognostic indicators2018-01-17T17:05:35-05:00
Natalizumab plus Interferon Beta-1a for Relapsing Multiple Sclerosis Natalizumab plus Interferon Beta-1a for Relapsing Multiple Sclerosis2018-01-17T17:05:05-05:00
Accumulation of irreversible disability in multiple sclerosis: From epidemiology to treatment Accumulation of irreversible disability in multiple sclerosis: From epidemiology to treatment2018-01-17T17:00:50-05:00
Natural History of Multiple Sclerosis with Childhood Onset Natural History of Multiple Sclerosis with Childhood Onset2018-01-17T17:00:50-05:00
Infections and the risk of relapse in multiple sclerosis Infections and the risk of relapse in multiple sclerosis2018-01-17T17:00:50-05:00
Vaccinations and the risk of relapse in MS Vaccinations and the risk of relapse in MS2018-01-17T17:00:50-05:00
